The Association of Medical Research Charities (AMRC) has consulted sector stakeholders on revisions to its IP guidance. The new guidance has been developed with the aim of simplifying policies and practices relating to IP and its commercialisation. This is, they say "in order to encourage those they fund to engage with translation and in particular to minimise the administrative burden on institutions or TTOs.” The proposed guidance is of direct relevance to PraxisAuril members, who work in research / enterprise and technology transfer offices. In our response we emphasised the need for KE practitioner representation in discussions of such guidance as too often we see decisions about commercialisation policy and practice made without the informed opinion of expert practitioners. This is to achieve better understanding of academic reserach commercialisation processes and procedures and the rationale for such, alongside the aims of Medical Charity funders. We would welcome working with the AMRC and its members to achieve this.